NIH Common Fund Data Ecosystem (CFDE) FAIR Rubric
A rubric for evaluating the FAIRness of NIH-CFDE Resources
Tags: nihcommonfund
URL(s):
View AssociationsRubric Assessments (626384)
| Assessment | Metrics | Date | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Target | Project | Contact information is provided for the creator(s) of the dataset. | Globally unique identifier | Machine-readable metadata | Standardized metadata | Resource identifier in metadata | Open, Free, Standardized Access protocol | Digital resource license | Metadata license | NIH program name is available for querying | NIH project name is available for querying | The institution that created this dataset is available | A biological assay is present and resolvable in CFDE-specified ontology (OBI) | A relevant anatomical part is present and resolvable in the UBERON Ontology | A relevant disease is present and resolvable in the MONDO Ontology | A relevant file type is present and resolvable in the EDAM Ontology | A relevant taxonomy is present and resolvable in the NCBITaxon Ontology | A relevant cell line is present and resolvable in the Cellosaurus Ontology | A landing page exists and is accessible | ||
| AZD7762 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| A443654 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Breast cell line dose response to target inhibition measured by high throughput microscopy | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| CGP60474 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Breast Cancer Deubiquitinating Enzyme (DUB) Inhibitor Profiling: Fixed-cell GR measures of 21 breast cell lines to 32 small molecule perturbagens. Dataset 1 of 2: Normalized growth rate inhibition values. | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| BI-2536 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| AZD-6482 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Cell signaling response to growth factors measured by high throughput microscopy | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| BGJ398 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| BMX-IN-1 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| (R)-Roscovitine KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| AZD4547 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Dasatinib KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| BIBF-1120 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| CH5424802 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| CYT387 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| CEP-701 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Breast Cancer Profiling Project, Drug Sensitivity 1: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens. Dataset 2 of 2: Calculated dose response metrics. | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| AZD-6244 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Breast Cancer Profiling Project, Gene Expression 1: Baseline mRNA sequencing on 35 breast cell lines | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.84) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Breast Cancer Profiling Project - Proteomics 1: 1 total proteome dataset for a 35-cell line breast cancer panel under basal conditions | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.84) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| CI-1033 KINOMEscan-2 | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| AS-252424 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| (s)-CR8 KINOMEscan | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yes (0.80) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| DCC-2036 KiNativ -- single dose experiment | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
yes (1.00) | no (0.00) | yesbut (0.76) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
